Beijing Defengrui Biotechnology Co. Ltd Report issue

For profit Phase 3
Founded: Beijing China (2019)

Organization Overview

First Clinical Trial
2020
NCT05075304
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Beijing Defengrei Biotechnology Co.,Ltd | Beijing Defengrui Biotechnology Co. Ltd